PolarisAIPharmaCorp is an API manufacturer based in South Korea.
| Molecule | Regulators | Docs |
|---|---|---|
| Apixaban | PMDA (Japan) | 1 |
| Aripiprazole | PMDA (Japan) | 1 |
| Entecavir | PMDA (Japan) | 1 |
| Glimepiride | PMDA (Japan) | 1 |
| オルメサルタンメドキソミル | PMDA (Japan) | 1 |
| ピオグリタゾン塩酸塩 | PMDA (Japan) | 1 |
| ピタバスタチンカルシウム | PMDA (Japan) | 1 |
| フルボキサミンマレイン酸塩 | PMDA (Japan) | 1 |
| プランルカスト水和物（製造専用） | PMDA (Japan) | 1 |
| モンテルカストナトリウム | PMDA (Japan) | 1 |
| レバミピド（製造専用） | PMDA (Japan) | 1 |
| ロキサチジン酢酸エステル塩酸塩 | PMDA (Japan) | 1 |
| Ｄｒｏｘｉｄｏｐａ | PMDA (Japan) | 1 |
| Ｄｕｌｏｘｅｔｉｎｅｈｙｄｒｏｃｈｌｏｒｉｄｅ | PMDA (Japan) | 1 |
| Ｅｂａｓｔｉｎｅ | PMDA (Japan) | 1 |
Also appears on these molecule pages
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on PolarisAIPharmaCorp, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.